Get started

Stockpicks

ASMB Technical Analysis 🧙Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program. If you want more trading ideas like this one,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:ASMBLong
by yura_trades
1
$BNGO can reach possible reversal point soon! Previous days, we saw massive correction on markets, that made BNGO follow overall market sentiment, which somehow made the stock change its direction from short-term price targets ( Targets which were strengthened by company news, technical indicators, trendline analysis, and Elliot waves analysis). During downtrend, stock reached its weekly support on EMA's and bounced back. For now we see possible reversal and breakout points to be watched. BNGO finished patenting its product and also acquired sales strategy and lots of positive news are dropped around it. Maxim analyst Jason McCarthy that was an early champion of the cytogenetics specialist, he believes the platform is in the early stage of its usage and its potential is only stating to be recognized, one month after he updated current trend price target to 14$ once again. Check Bngo official website for all the main news. Currently on 4h chart, we see BNGO is under 50MA but above 100MA, which explains its situation a lot. We see main break out line and areas that needs to be watched are highlighted on the chart. The price first needs to break out from current main resistance that it will meet soon. If happens so, MACD and 50MA will react on it instantly giving buy signals. Later if other resistances are broken easily we can see price going higher and higher. If it doesn't go bullish FOR SHORT TERM because of market situation, again same areas can act as supports. + Also keep in mind to watch overall market and economical situation if you are holding BNGO for short period. not financial advisor// do your DD
NASDAQ:BNGOLong
by UnknownUnicorn10617434
Berkshire Grey Announces Business Combination with $RAAC spacBerkshire Grey, a Leader in AI-Enabled Robotics and Automation Solutions, Announces Business Combination with Revolution Acceleration Acquisition Corp Combined company to have an estimated post-transaction equity value of up to $2.7 billion Transaction expected to provide up to $413 million in cash proceeds, including a fully committed PIPE of $165 million anchored by Chamath Palihapitiya, Founder and CEO of Social Capital, Hedosophia and funds and accounts managed by BlackRock Current Berkshire Grey shareholders Khosla Ventures, New Enterprise Associates, Canaan Partners and SoftBank Group Corp. rolling 100% of their equity in the combined company Berkshire Grey expects to have $507 million cash, which will be used to fund operations and support new and existing growth initiatives, and no debt on its balance sheet following the combination. The intellectual property supporting BG’s market-leading solutions is protected by more than 300 patent filings. The intellectual property supporting BG’s market-leading solutions is protected by more than 300 patent filings. Transaction is expected to close during the second quarter of 2021 and is subject to approval by RAAC’s stockholders and other customary closing conditions. finance.yahoo.com
R
by AlenCiken
$UAMY Announces Receipt of Warning Letter from NYSE AmericanUnited States Antimony Corporation Announces Receipt of Warning Letter from NYSE American The basis for the Letter is that the Company sold shares of its common stock in a manner that violated Sections 301 and 713 of the Company Guide. Trading in the Company's common stock has been halted since before the opening of trading on Wednesday, February 17, 2021, as NYSE Regulation has assessed these rule violations. The violations relate to two non-underwritten transactions involving the sale of an aggregate of 26,290,000 shares of common stock at a discount to the market price at the time of each transaction, with the first transaction, which closed on February 3, 2021, involving the sale of 15,300,000 shares of common stock at a purchase price of $0.70 per share, and with the second transaction, which closed on February 16, 2021, involving the sale of 10,990,000 shares of common stock at a purchase price of $1.30 per share. In light of the very close proximity in time of the two transactions and the fact that both transactions involved substantially the same group of purchasers, NYSE Regulation determined that these issuances should be aggregated for purposes of Section 713 of the Company Guide. Together, the two transactions covered approximately 34.4% of the common stock outstanding. Section 301 of the Company Guide states that a listed company is not permitted to issue, or to authorize its transfer agent or registrar to issue or register, additional securities of a listed class until it has filed an application for the listing of such additional securities and received notification from the NYSE American that the securities have been approved for listing. Section 713 of the Company Guide requires shareholder approval when additional shares to be issued in connection with a transaction involve the sale, issuance, or potential issuance of common stock (or securities convertible into common stock) equal to 20% or more of presently outstanding stock for less than the greater of book or market value of the stock. As stated in the Letter, the Company failed to submit a completed listing application in advance of the February 16, 2021 transaction to obtain advance approval as required by Section 301 of the Company Guide and also did not obtain shareholder approval for the aggregate issuance of 26,290,000 shares that exceeded 20% of the common stock of the Company outstanding as required by Section 713 of the Company Guide. NYSE Regulation noted in the Letter that, after it became aware that the Company had entered into a purchase agreement in relation to the second transaction, NYSE Regulation informed representatives of the Company that it would be a violation of the applicable NYSE American rules for the Company to close the second transaction without first obtaining shareholder approval . Notwithstanding this clear guidance from NYSE Regulation, the Company went ahead with closing the transaction without notifying the Exchange. The Company has been advised by NYSE Regulation that the Company's common stock will resume trading on the NYSE American following the issuance of this press release and the filing of a Current Report on Form 8-K disclosing the receipt of the Letter, which the Company anticipates will be prior to the open of trading on Friday, February 19, 2021. finance.yahoo.com
AMEX:UAMY
by AlenCiken
KeyBanc Capital analyst Philip Gibbs raised rating- $10 target $TMST surged higher on very heavy volume, after KeyBanc Capital analyst Philip Gibbs said it's time to buy the steel maker's stock as the macro recovery is unfolding. Gibbs raised his rating to overweight, after being at sector weight since July 2018, and set a $10 target for the stock, which is 19.8% above current levels. Gibbs said his new bullish view "post due diligence" reflects the macroeconomic recovery, better contract and spot pricing and widening raw material spreads, as well as "self-help," which includes cost cuts. The latest available data showed that short interest was 9.72% of the public float.
T
by AlenCiken
$BANT Next Step higher, Supernova! Legends! (fm @ozVest)Bantec, Inc., a product and service company, engages the distribution and integration of advanced low altitude unmanned aerial vehicles systems, services, and products worldwide. It provides product procurement, distribution, and logistics services. The company also offers drones; drone accessories, training, and services; counter-drone technology; certificates of authorization; and Waivers, as well as drone pilot services. In addition, it sells disinfecting products and equipment through its bantec.store website to facility owners in hospitals, universities, manufacturers, and building owners; supplies spare and replacement parts to federal government agencies, the U.S. military prime contractors, and commercial customers; and sells drones to law enforcement, fire departments, security companies, and the U.S. government. Bantec, Inc. was incorporated in 1972 and is headquartered in Little Falls, New Jersey.
OTC:BANTLong
by BADQOMOCAWGOWLD
1
AYX Technical Analysis 🧙Alteryx Inc is a software company that provides self-service data analytics software. Its software platform enables organizations to dramatically improve business outcomes and the productivity of business analysts. The firm offers solutions such as advanced analytics, location intelligence, data preparation, technology integrations, and others. It serves Financial Services; Healthcare; Retail; Transportation and Logistics; Oil and Gas; Pharmaceuticals and Biotechnology and other industries. The company generates its revenue from the sale of a subscription-based software platform. If you want more trading ideas like this one,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ALong
by yura_trades
3